HIPEC addition to SCS did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer patients. Both SCS alone and SCS with HIPEC groups exhibited similar safety profiles, ...
The FDA approved Abbott Laboratories ABT spinal cord stimulation (SCS) devices for chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results